Platelet-mediated thrombotic complications in patients with ET: Reversal by aspirin, platelet reduction, and not by coumadin

Blood Cells, Molecules, and Diseases

Volumn 36, Issue 2, 2006, Pages 199-205

  Michiels, Jan Jacques ^a,b   Berneman, Zwi ^a   Schroyens, Wilfried ^a   Koudstaal, Peter J ^c   Lindemans, Jan ^c   Van Vliet, Huub H D M ^c  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b Goodheart Institute   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Aspirin; Coronary artery disease; Coumadin; Erythromelalgia; Essential thrombocythemia; Polycythemia vera; Transient ischemic attacks

Indexed keywords

ACETYLSALICYLIC ACID; PROSTAGLANDIN SYNTHASE; WARFARIN;

ACUTE CORONARY SYNDROME; ARTICLE; BRAIN CIRCULATION; CELL PROLIFERATION; CLINICAL FEATURE; CORONARY ARTERY BLOOD FLOW; ERYTHROMELALGIA; HISTOLOGY; HUMAN; INFLAMMATION; MICROVASCULAR ISCHEMIA; MICROVASCULATURE; MIGRAINE; OCULAR ISCHEMIC SYNDROME; PERIPHERAL CIRCULATION; PHLEBOTOMY; POLYCYTHEMIA; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTHEMIA; THROMBOSIS;

ASPIRIN; BLOOD PLATELETS; ERYTHROMELALGIA; HUMANS; PLATELET COUNT; THROMBOCYTHEMIA, HEMORRHAGIC; THROMBOSIS; WARFARIN;

EID: 33645309100     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2005.12.021     Document Type: Article

References (17)

1. J.J. Michiels, J. Abels, J. Steketee, H.H.D.M. vanVliet, and V.D. Vuzevski Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis in thrombocythemia Ann. Intern. Med. 102 1985 466 471
2. J.J. Michiels, and Th. Van Joost Erythromelalgia and thrombocythemia. A causal relation J. Am. Acad. Dermatol. 22 1990 107 111
3. J.J. Michiels, F.W.J. Ten Kate, V.D. Vuzevski, and J. Abels Histopathology of erythromelalgia in thrombocythemia Histopathology 8 1984 669 678
4. K. Schör Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis Semin. Thromb. Hemost. 23 1997 343 349
5. P.J.J. Van Genderen, J.J. Michiels, R. van Strik, J. Lindemans, and H.H.D.M. van Vliet Platelet consumption in thrombocythemia complicated by erythromelalgia: reversal by aspirin Thromb. Haemost. 73 1995 210 214
6. J.J. Michiels, and F.J. Zijlstra Prostaglandin cyclooxygenase products but not thromboxane A2 are involved in the pathogenesis of erythromelalgia in thrombocythemia Mediat. Inflamm. 2 1993 385 389
7. R. Landolfi, G. Ciabattoni, P. Patrihnani, M.A.L. Castellana, E. Pogliani, B. Bizzi, and C. Patrono Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin-suppressible platelet activation in vivo Blood 80 1992 1965 1971
8. B. Rocca, G. Ciabattoni, R. Tartaglione, S. Cortelazzo, T. Barbui, C. Patrono, and R. Landolfi Increased thromboxane biosynthesis in essential thrombocythemia Thromb. Haemost. 74 1995 1225 12230
9. P.J.J. Van Genderen, F. Prins, J.J. Michiels, and K. Schrör Thromboxane-dependent platelet activation in vivo precedes arterial thrombosis in thrombocythaemia: a rationale for the use of low-dose aspirin as an antithrombotic agent Brit. J. Haematol. 104 1999 438 441
10. P.J.J. Van Genderen, I.S. Lucas, R. van Strik, V.D. Vuzevski, F. Prins, H.H.D.M. van Vliet, and J.J. Michiels Erythromelalgia in essential thrombocythemia is characterized by platelet activation and endothelial cell damage but not by thrombin generation Thromb. Haemost. 76 1996 333 338
11. J.J. Michiels, P. Koudstaal, A.H. Mulder, and H.H.D.M. van Vliet Transient neurologic and ocular manifestations in primary thombocythemia Neurology 43 1993 1107 1110
12. J.J. Michiels, P.J.J. Van Genderen, P.H.P. Janssen, and P. Koudstaal Atypical transient ischemic attacks in thrombocythemia of various myeloproliferative disorders Leuk. Lymphoma 22 Suppl. 1 1996 65 70
13. M.G. Scheffer, J.J. Michiels, M.L. Simoons, and J.R.T.C. Roelandt Thrombocythemia and coronary artery disease Am. Heat J. 22 1991 573 576
14. P. Fröhli, C. Graf, and K. Rhyner Die prophylaxe vasculärer komplikationen bei polycythaemia vera und primärer thrombozythämie mit niedrigdosierter acetylsalicylsäure Schweiz. Med. Wochenschr. 113 1983 1622 1627
15. M. Griesshammer, M. Bangerter, H.H.D.M. van Vliet, and J.J. Michiels Aspirin in essential thrombocythemia: status quo and quo vadis Semin. Thromb. Hemost. 23 1997 371 377
16. P.J.J. Van Genderen, P.G.H. Mulder, M. Waleboer, D. van de Moesdijk, and J.J. Michiels Prevention and treatment of thrombotic complications in essential thrombocythemia: efficacy and safety of aspirin Br. J. Haematol. 97 1997 179 184
17. R. Landolfi, R. Marchioli, J. Kutti, H. Gisslinger, G. Tognoni, C. Patrono, and T. Barbui Efficacy and safety of low-dose aspirin in polycythemia vera: results of the ECLAP trial N. Engl. J. Med. 350 2004 114 124